industry and reviewed court information on lawsuits brought against the pharmaceutical companies for the marketing of psychiatric medications for off-label uses in vulnerable populations such as children and the elderly, he said.???They performed this investigation without any compensation or without concern for course credit, which is very impressive, Robbins said.